News Conference News ACC 2023 Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2 Michael O'Riordan March 09, 2023
News Opinion Editor's Corner ACC 2023 What’s Going to Be Hot at ACC/WCC 2023? Shelley Wood February 27, 2023
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Conference News ACC 2021 Use of a Rapid, High-Sensitivity Troponin Protocol Doesn’t Boost 1-Year Outcomes Todd Neale May 16, 2021
News Conference News ACC 2019 Myocardial Injury Often Miscoded as Type 2 MI L.A. McKeown April 02, 2019
Presentation ACC 2018 MANAGE: Dabigatran in Myocardial Injury After Noncardiac Surgery Presenter: Philip Devereaux March 12, 2018
News Conference News ACC 2018 MANAGE Suggests Dabigatran Could Be Useful for Treating Myocardial Injury After Noncardiac Surgery Todd Neale March 11, 2018
News Conference News ACC 2018 ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More Shelley Wood March 11, 2018
News Conference News ACC 2018 Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery Yael L. Maxwell March 10, 2018
News Conference News ACC 2017 Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests Todd Neale March 22, 2017